Acorah Software Products - Accounts Production 16.7.461 false true true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 04104962 Ms Danielle Williams Ms Catherine Jenkins iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 04104962 2024-03-31 04104962 2025-03-31 04104962 2024-04-01 2025-03-31 04104962 frs-core:CurrentFinancialInstruments 2025-03-31 04104962 frs-core:Non-currentFinancialInstruments 2025-03-31 04104962 frs-core:PlantMachinery 2025-03-31 04104962 frs-core:PlantMachinery 2024-04-01 2025-03-31 04104962 frs-core:PlantMachinery 2024-03-31 04104962 frs-core:ShareCapital 2025-03-31 04104962 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 04104962 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 04104962 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 04104962 frs-bus:SmallEntities 2024-04-01 2025-03-31 04104962 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 04104962 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 04104962 frs-core:ListedExchangeTraded 2025-03-31 04104962 frs-core:ListedExchangeTraded 2024-03-31 04104962 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-03-31 04104962 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-03-31 04104962 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-03-31 04104962 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-03-31 04104962 frs-bus:Director1 2024-04-01 2025-03-31 04104962 frs-bus:Director2 2024-04-01 2025-03-31 04104962 frs-countries:EnglandWales 2024-04-01 2025-03-31 04104962 2023-03-31 04104962 2024-03-31 04104962 2023-04-01 2024-03-31 04104962 frs-core:CurrentFinancialInstruments 2024-03-31 04104962 frs-core:Non-currentFinancialInstruments 2024-03-31 04104962 frs-core:ShareCapital 2024-03-31 04104962 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 04104962
Med-Co (Europe) Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 04104962
2025 2024
Notes £ £ £ £
FIXED ASSETS
Investments 5 100 100
100 100
CURRENT ASSETS
Debtors 6 513,447 504,493
Cash at bank and in hand 502 776
513,949 505,269
Creditors: Amounts Falling Due Within One Year 7 (26,136 ) (29,235 )
NET CURRENT ASSETS (LIABILITIES) 487,813 476,034
TOTAL ASSETS LESS CURRENT LIABILITIES 487,913 476,134
Creditors: Amounts Falling Due After More Than One Year 8 (666,746 ) (627,161 )
NET LIABILITIES (178,833 ) (151,027 )
CAPITAL AND RESERVES
Called up share capital 9 200,000 200,000
Profit and Loss Account (378,833 ) (351,027 )
SHAREHOLDERS' FUNDS (178,833) (151,027)
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Ms Danielle Williams
Director
9 December 2025
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Med-Co (Europe) Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 04104962 . The registered office is 120 St. Teilo Street, Pontarddulais, Swansea, SA4 8RE.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 33% on cost
2.5. Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 6)
2 6
4. Tangible Assets
Plant & Machinery
£
Cost
As at 1 April 2024 5,299
As at 31 March 2025 5,299
Depreciation
As at 1 April 2024 5,299
As at 31 March 2025 5,299
Net Book Value
As at 31 March 2025 -
As at 1 April 2024 -
Page 3
Page 4
5. Investments
Listed
£
Cost or Valuation
As at 1 April 2024 100
As at 31 March 2025 100
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 100
As at 1 April 2024 100
6. Debtors
2025 2024
£ £
Due within one year
Trade debtors 12,504 67,997
Other debtors 41,357 39,421
53,861 107,418
Due after more than one year
Amounts owed by group undertakings 459,586 397,075
513,447 504,493
7. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Trade creditors 2,288 9,501
Bank loans and overdrafts 10,170 10,170
Other creditors 1,450 1,450
Taxation and social security 12,228 8,114
26,136 29,235
8. Creditors: Amounts Falling Due After More Than One Year
2025 2024
£ £
Bank loans 2-5 years - 2,100
Amounts owed to group undertakings 664,572 614,892
Other creditors 2,174 10,169
666,746 627,161
9. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 200,000 200,000
Page 4
Page 5
10. Related Party Transactions
The company was owed £30,000 (2024: £30,000) from C M Jenkins, a majority shareholder of the group. This loan is interest free, unsecured and repayable within 1 year.
Page 5